HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterogeneity of glucose metabolism in corticobasal degeneration.

Abstract
A positron emission tomography (PET) study on the regional cerebral glucose metabolism (rCMRglc) was performed in six patients with corticobasal degeneration (CBD). The clinical features included asymmetrical parkinsonism with apraxia, were related to the cerebral cortical and basal ganglionic dysfunction. An MRI study showed all cases to have asymmetrical atrophy in the front-parietal cortex contralateral to the dominantly affected limb; however, no case was pathologically verified. A PET study revealed three cases to have asymmetrical glucose hypometabolism in the parietal lobe and thalamus, which was compatible with the results of previous reports. However, two patients demonstrated symmetrical glucose hypometabolism in the frontal lobe, striatum and parietal lobe while one case had a diffuse hypometabolism, in spite of a marked asymmetry of the neurological findings. These results therefore suggest the heterogeneity of the glucose hypometabolism in CBD based on the PET findings.
AuthorsT Taniwaki, T Yamada, T Yoshida, M Sasaki, Y Kuwabara, M Nakagawa, F Mihara, S Motomura, H Shigetou, J Kira
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 161 Issue 1 Pg. 70-6 (Nov 26 1998) ISSN: 0022-510X [Print] Netherlands
PMID9879684 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucose
Topics
  • Aged
  • Basal Ganglia (diagnostic imaging, pathology)
  • Brain (metabolism)
  • Cerebral Cortex (diagnostic imaging, pathology)
  • Female
  • Glucose (metabolism)
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Nerve Degeneration (diagnosis, metabolism, pathology)
  • Tissue Distribution
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: